IP Library Granted Patent US 7,238,183
Granted Patent B2
US 7,238,183 · App. 10/774,478 · Granted Jul 3, 2007

System and method for treating skin

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,238,183
App. No.
10/774,478
Granted
Jul 3, 2007
Kind
B2
Abstract

System and method for treating a skin target. A temperature effector creates a temperature difference between the target and the skin tissue surrounding the target such that the target is at a higher temperature than the surrounding tissue by at least 5° C. One or more RF electrodes are attached to the skin and RF energy is applied.

Claims (18)

1. A system for treating a skin surface target comprising:

(a) an applicator containing at least two RF electrodes configured to be applied to the skin surface, so as to apply an RF current to a skin surface area located between the electrodes when the applicator is applied to the skin surface, the skin surface area containing at least a portion of the target;

(b) a temperature effector configured to create a temperature difference between the target and a skin surface surrounding the target such that the target is at a temperature that is at least 5° C. higher than the surrounding skin surface, wherein the temperature effector heats the target.

2. The system according to claim 1 wherein the temperature effector comprises a light source configured to apply optical energy to the target.

3. A method for treating a skin surface target comprising:

(a) creating a temperature gradient between the target and a skin surface surrounding the target such that the target is at a temperature that is at least 5° C. higher than the surrounding skin surface; and

(b) applying RF energy to a skin surface area containing at least a portion of the target, wherein the temperature gradient is created by heating the target.

4. The method according to claim 3 wherein the target is heated by applying optical energy to the target with an intensity of about 5 to about 100 Joules/cm 2 for about 1 to 200 msec.

5. The method according to claim 3 wherein the target is selected from the group comprising a vascular lesion, pigmented lesion, hair follicle, wrinkle and acne.

6. The method of claim 3 wherein the RF energy has a power level of 5 to 200 W.

7. A method for treating a skin surface target comprising:

(a) activating a temperature effector to heat the target in order to create a temperature gradient between the target and a skin surface surrounding the target such that the target is at a temperature that is at least 5° C. higher than the surrounding skin surface;

(b) terminating the activity of the temperature effector; and

(c) after said terminating step, applying RF energy to a skin surface area containing at least a portion of the target.

8. A system for treating a skin surface target comprising:

an applicator containing at least two RF electrodes configured to be applied to the skin surface, so as to apply an RF current to a skin surface area located between the electrodes when the applicator is applied to the skin surface, the skin surface area containing at least a portion to the target;

a temperature effector configured to heat the target in order to create a temperature difference between the target and skin surface surrounding the target such that the target is at a temperature that is at least 5° C. higher than the surrounding skin surface; and

a processor coupled to said temperature effector and said RF electrodes and configured to sequentially activate said temperature effector, terminate the activity of said temperature effector, and then activate said RF electrodes.

Assignments (6)
NOTICE OF SUCCESSION OF AGENCY AT REEL/FRAME 059593/0269 Recorded May 29, 2026
From: BARCLAYS BANK PLC, AS PRIOR COLLATERAL AGENT
To: HSBC BANK USA, N.A., AS SUCCESSOR COLLATERAL AGENT
Reel/Frame 075648/0952 →
RELEASE (REEL 043925 / FRAME 0001) Recorded Apr 4, 2022
From: ING CAPITAL LLC
To: SYNERON MEDICAL LTD.; CANDELA CORPORATION; PRIMAEVA CORPORATION
Reel/Frame 059593/0131 →
SECURITY AGREEMENT Recorded Apr 4, 2022
From: CANDELA CORPORATION; SYNERON MEDICAL LTD.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 059593/0269 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED AT REEL: 015610 FRAME: 0585. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Nov 14, 2017
From: MICHAEL KREINDEL
To: SYNERON MEDICAL LTD.
Reel/Frame 044442/0928 →
SECURITY AGREEMENT Recorded Sep 20, 2017
From: SYNERON MEDICAL LTD.; CANDELA CORPORATION; PRIMAEVA CORPORATION
To: ING CAPITAL LLC, AS COLLATERAL AGENT
Reel/Frame 043925/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2004
From: KREINDEL, MICHAEL
To: SYNERON MEDICAL LTD., ISRAELI COMPANY, OF
Reel/Frame 015610/0585 →